Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. 1989

M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
Pathological Institute, University of Tübingen, FRG.

A retrospective long-term study (average follow-up time 5.2 years) of 334 patients with idiopathic membranous glomerulonephritis (MGN) was carried out with the following results: 1) MGN was found to have a relatively good prognosis when all cases were considered together: 5-year kidney survival rate (KSR) -88%, and 10-year KSR -77%. 2) Univariate survivorship analysis showed the following morphological and clinical parameters to be associated with an increased risk of terminal renal insufficiency or death from renal disease: a) tubulo-interstitial changes; b) glomerular stage III as opposed to stages I and II; c) elevation of serum creatinine concentration at the time of the biopsy; d) arterial hypertension at the time of the biopsy. 3) Multivariate analysis showed that only tubulo-interstitial changes (interstitial fibrosis and/or acute renal failure) found at the time of the biopsy and their clinical correlate, serum creatinine concentration, were significant and therefore of definite prognostic importance. 4) Unsystematic therapy with steroids and/or cytostatic agents does not improve the long-term prognosis of MGN. 5) The cause of disease in the tubulo-interstitial system in MGN is discussed. Interstitial fibrosis is considered to develop possibly as a consequence of unresorbed interstitial edema which can develop during an episode of acute renal failure. Coexisting T-cell-mediated disease in the region of the intertubular capillaries is also considered as a possible factor in the development of interstitial fibrosis.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009395 Nephritis, Interstitial Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction. Interstitial Nephritis,Nephritis, Tubulointerstitial,Tubulointerstitial Nephritis,Interstitial Nephritides,Nephritides, Interstitial,Nephritides, Tubulointerstitial,Tubulointerstitial Nephritides
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females

Related Publications

M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
February 1986, Nihon Jinzo Gakkai shi,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
October 1988, Clinical nephrology,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
October 1988, Klinicheskaia meditsina,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
September 1991, Clinical nephrology,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
January 1979, The American journal of medicine,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
September 1995, Scandinavian journal of urology and nephrology,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
January 1991, International urology and nephrology,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
December 1963, Annales de pediatrie,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
August 1995, Clinical nephrology,
M Wehrmann, and A Bohle, and O Bogenschütz, and R Eissele, and A Freislederer, and C Ohlschlegel, and G Schumm, and C Batz, and H V Gärtner
February 1987, Pathology, research and practice,
Copied contents to your clipboard!